发明名称 Trk-INHIBITING COMPOUND
摘要 PROBLEM TO BE SOLVED: To provide a drug effective in prophylaxis and/or therapy for receptor tyrosine kinase (Trk)-related diseases such as pain, pruritus, lower urinary tract dysfunction, asthma, allergic rhinitis, inflammatory bowel disease or Chagas disease.SOLUTION: The present invention relates to a compound represented by the formula: {1-{2-[4-(2-amino-5-chloro-3-pyridinyl) phenoxy]-5-pyrimidinyl}-3-[2-(methylsulfonyl)-5-(trifluoromethyl) phenyl]urea}, its salt, its N-oxide, its solvate, or a prodrug of them.SELECTED DRAWING: None
申请公布号 JP2016138121(A) 申请公布日期 2016.08.04
申请号 JP20160037949 申请日期 2016.02.29
申请人 ONO PHARMACEUT CO LTD 发明人 TAKEUCHI ATSUSHI;ITAYA SATOSHI;HASHIMURA KAZUYA;IKURA MASAYASU;TONO KATSUTO;YASUHIRO TETSUYA;NAGAURA TAKESHI
分类号 C07D401/12;A61K31/506;A61P1/04;A61P11/02;A61P11/06;A61P13/02;A61P17/04;A61P33/10;A61P43/00 主分类号 C07D401/12
代理机构 代理人
主权项
地址